Volume | 112,239 |
|
|||||
News | - | ||||||
Day High | 20.77 | Low High |
|||||
Day Low | 19.335 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Castle Biosciences Inc | CSTL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
19.54 | 19.335 | 20.77 | 20.34 | 19.51 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
2,113 | 112,239 | US$ 20.27 | US$ 2,275,459 | - | 9.2601 - 26.70 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:53:15 | 1 | US$ 20.01 | USD |
Castle Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
559.16M | 27.45M | - | 219.79M | -57.47M | -2.09 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Castle Biosciences News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CSTL Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 19.04 | 20.77 | 18.76 | 19.69 | 144,856 | 1.30 | 6.83% |
1 Month | 22.10 | 22.67 | 18.50 | 20.45 | 141,357 | -1.76 | -7.96% |
3 Months | 23.31 | 25.60 | 17.42 | 21.52 | 231,236 | -2.97 | -12.74% |
6 Months | 12.70 | 25.60 | 12.35 | 20.37 | 243,626 | 7.64 | 60.16% |
1 Year | 22.52 | 26.70 | 9.2601 | 17.84 | 387,855 | -2.18 | -9.68% |
3 Years | 68.12 | 78.92 | 9.2601 | 28.78 | 280,900 | -47.78 | -70.14% |
5 Years | 20.00 | 107.69 | 9.2601 | 34.54 | 252,967 | 0.34 | 1.70% |
Castle Biosciences Description
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. |